AAAAAA

   
Results: 1-16 |
Results: 16
Local instillation of Staphylococcus aureus peptidoglycan at operation prevents wound healing impairment after trauma
Authors: Mavi, G Qiu, JG Factor, S Teh, EL Leon, W Levenson, SM
Citation: G. Mavi et al., Local instillation of Staphylococcus aureus peptidoglycan at operation prevents wound healing impairment after trauma, J TRAUMA, 51(4), 2001, pp. 728-735
Cervical dystonia severity scale reliability study
Authors: O'Brien, C Brashear, A Cullis, P Truong, D Molho, E Jenkins, S Wojcieszek, J O'Neil, T Factor, S Seeberger, L
Citation: C. O'Brien et al., Cervical dystonia severity scale reliability study, MOVEMENT D, 16(6), 2001, pp. 1086-1090
The natural history of embouchure dystonia
Authors: Frucht, SJ Fahn, S Greene, PE O'Brien, C Gelb, M Truong, DD Welsh, J Factor, S Ford, B
Citation: Sj. Frucht et al., The natural history of embouchure dystonia, MOVEMENT D, 16(5), 2001, pp. 899-906
TBX1 is responsible for cardiovascular defects in Velo-Cardio-Facial/DiGeorge syndrome
Authors: Merscher, S Funke, B Epstein, JA Heyer, J Puech, A Lu, MM Xavier, RJ Demay, MB Russell, RG Factor, S Tokooya, K Jore, BS Lopez, M Pandita, RK Lia, M Carrion, D Xu, H Schorle, H Kobler, JB Scambler, P Wynshaw-Boris, A Skoultchi, AI Morrow, BE Kucherlapati, R
Citation: S. Merscher et al., TBX1 is responsible for cardiovascular defects in Velo-Cardio-Facial/DiGeorge syndrome, CELL, 104(4), 2001, pp. 619-629
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease
Authors: Shoulson, I Penney, J McDermott, M Kieburtz, K Schwid, SR Kayson, E Chase, T Fahn, S Greenamyre, JT Lang, A Siderowf, A Pearson, N Harrison, M Rost-Ruffner, E Colcher, A Lloyd, M Matthews, M Pahwa, R McGuire, D Lew, MF Schuman, S Marek, K Broshjeit, S Factor, S Brown, D Feigin, A Mazurkiewicz, J Ford, B Jennings, D Dillon, S Comella, C Blasucci, L Janko, K Shulman, L Wiener, W Bateman-Rodriguez, D Carrion, A Suchowersky, O Lafontaine, AL Pantella, C Siemers, E Belden, J Davies, R Lannon, M Grimes, D Gray, P Martin, W Kennedy, L Adler, C Newman, S Hammerstad, J Stone, C Lewitt, P Bardram, K Mistura, K Miyasaki, J Johnston, L Cha, JHJ Tennis, M Panisset, M Hall, J Tetrud, J Friedlander, J Hauser, R Gauger, L Rodnitzky, R Deleo, A Dobson, J Seeberger, L Dingmann, C Tarsy, D Ryan, P Elmer, L Ruzicka, D Stacy, M Brewer, M Locke, B Baker, D Casaceli, C Day, D Florack, M Hodgeman, K Laroia, N Nobel, R Orme, C Rexo, L Rothenburgh, K Sulimowicz, K Watts, A Wratni, E Tariot, P Cox, C Leventhal, C Alderfer, V Craun, AM Frey, J McCree, L McDermott, J Cooper, J Holdich, T Read, B
Citation: I. Shoulson et al., A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease, NEUROLOGY, 56(4), 2001, pp. 455-462
A randomized controlled trial comparing pramipexole with levodopa in earlyParkinson's disease: Design and methods of the CALM-PD study
Authors: Holloway, R Shoulson, I Fahn, S Kieburtz, K Lang, A Marek, K McDermott, M Seibyl, J Weiner, W Welsh, M Kamp, C Day, D Pahwa, R Smith, D McGuire, D Barclay, L Sutherland, L Hildebrand, K Hubble, J Weeks, C LeWitt, P Mistura, K Bloomfield, W Miyasaki, J Duff, J Sime, E Suchowersky, O Argatoff, P Andreas, Y Kurth, M Brewer, M Russell, D Fussell, B Ford, B Dillon, S Hammerstad, J Stone, C Riley, D Rainey, P Standaert, D Tennis, M Wooten, F Rost-Ruffner, E Factor, S Brown, D Jankovic, J Beach, J Kurlan, R Gardiner, I Panisset, M Amyot, D Hall, J Rajout, A Wilson, W McCullan, L Brown, K Clark, R Rodnitzky, R Dobson, J Shults, C Fontaine, D Waters, C Welsh, M Pfeiffer, R Rast, S Bujak, G Casaceli, C Freimuth, A Hodgeman, K Honsinger, K Watts, A Hall, WJ Leventhal, CM Reich, S Tariot, P Balgoyen, D Corak, D Corrigan, M Driver, M Fraser, TJ Lai, PY Gomez-Mancilla, B Munting, J Peters, G Rowland, C Sullivan, H Trasky, R Wright, G Berber, E Morris, J Mills, D Hallak, L Rines, S
Citation: R. Holloway et al., A randomized controlled trial comparing pramipexole with levodopa in earlyParkinson's disease: Design and methods of the CALM-PD study, CLIN NEUROP, 23(1), 2000, pp. 34-44
Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial
Authors: Holloway, R Shoulson, I Kieburtz, K McDermott, M Tariot, P Kamp, C Day, D Shinaman, A Fahn, S Lang, A Marek, K Seibyl, J Weiner, W Welsh, M Pahwa, R Coe, S Barclay, L Sutherland, L Hildebrand, K Hubble, J Weeks, C LeWitt, P Miyasaki, J Duff, J Sime, E Suchowersky, O Stacy, M Kurth, M Brewer, M Harrigan, M Russell, DS Fussell, B Ford, B Dillon, S Hammerstad, J Stone, C Riley, D Rainey, P Standaert, D Tennis, M Wooten, F Rost-Ruffner, E Factor, S Brown, D Jankovic, J Atassi, F Kurlan, R Gardiner, I Panisset, M Amyot, D Hall, J Rajput, A Shirley, T Rodnitzky, R Dobson, J Shults, C Fontaine, D Waters, C Welsh, M Schuman, S Pfeiffer, R Rast, S Pfeiffer, B Brocht, A Casaceli, C Daigneault, S Hodgeman, K Honsinger, K O'Connell, C Watts, A
Citation: R. Holloway et al., Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial, J AM MED A, 284(15), 2000, pp. 1931-1938
Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit
Authors: Foca, M Jakob, K Whittier, S Della Latta, P Factor, S Rubenstein, D Saiman, L
Citation: M. Foca et al., Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit, N ENG J MED, 343(10), 2000, pp. 695-700
The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: Summary of three controlled clinical trials
Authors: Lew, MF Brashear, A Factor, S
Citation: Mf. Lew et al., The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: Summary of three controlled clinical trials, NEUROLOGY, 55(12), 2000, pp. S29-S35
Normal cardiovascular development in mice deficient for 16 genes in 550 kbof the velocardiofacial/DiGeorge syndrome region
Authors: Puech, A Saint-Jore, B Merscher, S Russell, RG Cherif, D Sirotkin, H Xu, H Factor, S Kucherlapati, R Skoultchi, AI
Citation: A. Puech et al., Normal cardiovascular development in mice deficient for 16 genes in 550 kbof the velocardiofacial/DiGeorge syndrome region, P NAS US, 97(18), 2000, pp. 10090-10095
Wound healing: Captopril, an angiogenesis inhibitor, and Staphylococcus aureus peptidoglycan
Authors: Qiu, JG Factor, S Chang, TH Knighton, D Nadel, H Levenson, SM
Citation: Jg. Qiu et al., Wound healing: Captopril, an angiogenesis inhibitor, and Staphylococcus aureus peptidoglycan, J SURG RES, 92(2), 2000, pp. 177-185
Levodopa in the treatment of Parkinson's disease: A consensus meeting
Authors: Agid, Y Ahlskog, E Albanese, A Calne, D Chase, T De Yebenes, J Factor, S Fahn, S Gershanik, O Goetz, C Koller, W Kurth, M Lang, A Lees, A Lewitt, P Marsden, D Melamed, E Michel, PP Mizuno, Y Obeso, J Oertel, W Olanow, W Poewe, W Pollak, P Przedzorski, S Quinn, N Raisman-Vozari, R Rajput, A Stocchi, F Tolosa, E
Citation: Y. Agid et al., Levodopa in the treatment of Parkinson's disease: A consensus meeting, MOVEMENT D, 14(6), 1999, pp. 911-913
Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease
Authors: Friedman, J Lannon, M Comella, C Factor, S Kurlan, R Richard, I Parsa, M Pfeiffer, R Davies, R Janko, K Brown, D Gardner, I Pearson, N Large, K Rast, S Oakes, D Goetz, C Paulson, G Marshall, F Kieburtz, K Rudolph, A Bourgeois, K Casacelli, C Freimuth, A Guthrie, B Pelusio, R Watts, A Tariot, P Raubertas, R Greenamyre, T
Citation: J. Friedman et al., Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease, N ENG J MED, 340(10), 1999, pp. 757-763
Autoimmune myocarditis does not require B cells for antigen presentation
Authors: Malkiel, S Factor, S Diamond, B
Citation: S. Malkiel et al., Autoimmune myocarditis does not require B cells for antigen presentation, J IMMUNOL, 163(10), 1999, pp. 5265-5268
Isolation of Haemophilus influenzae in central Asia
Authors: LaClaire, L Bronsdon, M Factor, S Suleymanova, F Chorba, T Schwartz, B Facklam, R
Citation: L. Laclaire et al., Isolation of Haemophilus influenzae in central Asia, EUR J CL M, 17(10), 1998, pp. 746-747
Escalating interferon-alpha-2b dose for patients with chronic hepatitis C
Authors: De La Riva, E Garcia-Carrasquillo, RJ Puppo, MD Mustacchia, PJ Factor, S Joe, A Finegold, J Riley, TH Sarabanchong, V Ligresti, RJ Markowitz, DD McMahon, DJ Magun, AM Worman, HJ
Citation: E. De La Riva et al., Escalating interferon-alpha-2b dose for patients with chronic hepatitis C, HEP-GASTRO, 45(24), 1998, pp. 2308-2314
Risultati: 1-16 |